1. Home
  2. AZTA vs DKL Comparison

AZTA vs DKL Comparison

Compare AZTA & DKL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AZTA
  • DKL
  • Stock Information
  • Founded
  • AZTA 1978
  • DKL 2012
  • Country
  • AZTA United States
  • DKL United States
  • Employees
  • AZTA N/A
  • DKL N/A
  • Industry
  • AZTA Industrial Machinery/Components
  • DKL Natural Gas Distribution
  • Sector
  • AZTA Technology
  • DKL Energy
  • Exchange
  • AZTA Nasdaq
  • DKL Nasdaq
  • Market Cap
  • AZTA 1.8B
  • DKL 2.1B
  • IPO Year
  • AZTA 1995
  • DKL N/A
  • Fundamental
  • Price
  • AZTA $26.77
  • DKL $37.80
  • Analyst Decision
  • AZTA Buy
  • DKL Buy
  • Analyst Count
  • AZTA 3
  • DKL 4
  • Target Price
  • AZTA $50.67
  • DKL $44.25
  • AVG Volume (30 Days)
  • AZTA 979.4K
  • DKL 206.6K
  • Earning Date
  • AZTA 05-07-2025
  • DKL 05-07-2025
  • Dividend Yield
  • AZTA N/A
  • DKL 11.64%
  • EPS Growth
  • AZTA N/A
  • DKL 7.97
  • EPS
  • AZTA N/A
  • DKL 2.98
  • Revenue
  • AZTA $669,171,000.00
  • DKL $938,491,000.00
  • Revenue This Year
  • AZTA N/A
  • DKL $15.88
  • Revenue Next Year
  • AZTA $5.38
  • DKL $0.37
  • P/E Ratio
  • AZTA N/A
  • DKL $12.69
  • Revenue Growth
  • AZTA 4.70
  • DKL N/A
  • 52 Week Low
  • AZTA $24.06
  • DKL $34.59
  • 52 Week High
  • AZTA $63.58
  • DKL $45.71
  • Technical
  • Relative Strength Index (RSI)
  • AZTA 43.19
  • DKL 42.85
  • Support Level
  • AZTA $23.91
  • DKL $38.25
  • Resistance Level
  • AZTA $27.06
  • DKL $39.65
  • Average True Range (ATR)
  • AZTA 1.41
  • DKL 1.14
  • MACD
  • AZTA 0.57
  • DKL 0.11
  • Stochastic Oscillator
  • AZTA 67.14
  • DKL 39.80

About AZTA Azenta Inc.

Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has two reportable segments that are Life Sciences Products and Life Sciences Services. It generates a substantial part of its revenue from its Life Sciences Services segment.

About DKL Delek Logistics Partners L.P. Common Units representing Limited Partner Interests

Delek Logistics Partners LP owns and operates logistics and marketing assets for crude oil and intermediate and refined products. The company's segment includes gathering and processing; wholesale marketing and terminalling; storage and transportation and investment in pipeline joint ventures. It generates maximum revenue from the wholesale marketing and terminalling segment, which provides marketing services for the refined products output of the Delek Holdings' refineries, engages in wholesale activity at its terminals and terminals owned by third parties, whereby it purchases light product for sale and exchange to third parties, and provides terminalling services at its refined products terminals to independent third parties and Delek Holdings.

Share on Social Networks: